416 related articles for article (PubMed ID: 24605939)
1. Therapeutic potential of cannabinoids in schizophrenia.
Kucerova J; Tabiova K; Drago F; Micale V
Recent Pat CNS Drug Discov; 2014 Apr; 9(1):13-25. PubMed ID: 24605939
[TBL] [Abstract][Full Text] [Related]
2. Endocannabinoid system in sexual motivational processes: Is it a novel therapeutic horizon?
Androvicova R; Horacek J; Stark T; Drago F; Micale V
Pharmacol Res; 2017 Jan; 115():200-208. PubMed ID: 27884725
[TBL] [Abstract][Full Text] [Related]
3. Endocannabinoid system and mood disorders: priming a target for new therapies.
Micale V; Di Marzo V; Sulcova A; Wotjak CT; Drago F
Pharmacol Ther; 2013 Apr; 138(1):18-37. PubMed ID: 23261685
[TBL] [Abstract][Full Text] [Related]
4. Role of the Endocannabinoid System in the Pathophysiology of Schizophrenia.
Fakhoury M
Mol Neurobiol; 2017 Jan; 54(1):768-778. PubMed ID: 26768595
[TBL] [Abstract][Full Text] [Related]
5. Phytocannabinoids for Cancer Therapeutics: Recent Updates and Future Prospects.
Patil KR; Goyal SN; Sharma C; Patil CR; Ojha S
Curr Med Chem; 2015; 22(30):3472-501. PubMed ID: 26179998
[TBL] [Abstract][Full Text] [Related]
6. The neurobiology and evolution of cannabinoid signalling.
Elphick MR; Egertová M
Philos Trans R Soc Lond B Biol Sci; 2001 Mar; 356(1407):381-408. PubMed ID: 11316486
[TBL] [Abstract][Full Text] [Related]
7. The Endocannabinoid System Modulating Levels of Consciousness, Emotions and Likely Dream Contents.
Murillo-Rodriguez E; Pastrana-Trejo JC; Salas-Crisóstomo M; de-la-Cruz M
CNS Neurol Disord Drug Targets; 2017; 16(4):370-379. PubMed ID: 28240187
[TBL] [Abstract][Full Text] [Related]
8. Neuromodulatory role of the endocannabinoid signaling system in alcoholism: an overview.
Basavarajappa BS; Hungund BL
Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):287-99. PubMed ID: 12052043
[TBL] [Abstract][Full Text] [Related]
9. Endocannabinoid system: emerging role from neurodevelopment to neurodegeneration.
Basavarajappa BS; Nixon RA; Arancio O
Mini Rev Med Chem; 2009 Apr; 9(4):448-62. PubMed ID: 19356123
[TBL] [Abstract][Full Text] [Related]
10. Druggable Targets in Endocannabinoid Signaling.
Gregus AM; Buczynski MW
Adv Exp Med Biol; 2020; 1274():177-201. PubMed ID: 32894511
[TBL] [Abstract][Full Text] [Related]
11. Cannabinoid pharmacology in the cardiovascular system: potential protective mechanisms through lipid signalling.
Hiley CR; Ford WR
Biol Rev Camb Philos Soc; 2004 Feb; 79(1):187-205. PubMed ID: 15005177
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacological exploitation of the endocannabinoid system: new perspectives for the treatment of depression and anxiety disorders?].
Saito VM; Wotjak CT; Moreira FA
Braz J Psychiatry; 2010 May; 32 Suppl 1():S7-14. PubMed ID: 20512266
[TBL] [Abstract][Full Text] [Related]
13. A systematic review of phytocannabinoid exposure on the endocannabinoid system: Implications for psychosis.
Jacobson MR; Watts JJ; Boileau I; Tong J; Mizrahi R
Eur Neuropsychopharmacol; 2019 Mar; 29(3):330-348. PubMed ID: 30635160
[TBL] [Abstract][Full Text] [Related]
14. An introduction to the endocannabinoid system: from the early to the latest concepts.
De Petrocellis L; Di Marzo V
Best Pract Res Clin Endocrinol Metab; 2009 Feb; 23(1):1-15. PubMed ID: 19285257
[TBL] [Abstract][Full Text] [Related]
15. Cannabis and cannabinoids: pharmacology and rationale for clinical use.
Pertwee RG
Forsch Komplementarmed; 1999 Oct; 6 Suppl 3():12-5. PubMed ID: 10575283
[TBL] [Abstract][Full Text] [Related]
16. Cannabis and schizophrenia: towards a cannabinoid hypothesis of schizophrenia.
Müller-Vahl KR; Emrich HM
Expert Rev Neurother; 2008 Jul; 8(7):1037-48. PubMed ID: 18590475
[TBL] [Abstract][Full Text] [Related]
17. The endocannabinoid system: its general strategy of action, tools for its pharmacological manipulation and potential therapeutic exploitation.
Di Marzo V
Pharmacol Res; 2009 Aug; 60(2):77-84. PubMed ID: 19559360
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic potential of cannabinoids in CNS disease.
Croxford JL
CNS Drugs; 2003; 17(3):179-202. PubMed ID: 12617697
[TBL] [Abstract][Full Text] [Related]
19. Pharmacotherapeutic targeting of the endocannabinoid signaling system: drugs for obesity and the metabolic syndrome.
Vemuri VK; Janero DR; Makriyannis A
Physiol Behav; 2008 Mar; 93(4-5):671-86. PubMed ID: 18155257
[TBL] [Abstract][Full Text] [Related]
20. Immune system: a possible nexus between cannabinoids and psychosis.
Suárez-Pinilla P; López-Gil J; Crespo-Facorro B
Brain Behav Immun; 2014 Aug; 40():269-82. PubMed ID: 24509089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
